content

Processa Pharmaceuticals Receives Orphan Designation Status For PCS499 In Necrobiosis Lipoidica From The FDA

Processa Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have a high...

ChargePoint Technology Reinforces Asia Presence withGrowth in China and Japan

Powder containment and aseptic transfer valve specialist, ChargePoint Technology has achieved triple-digit growth in key Asian markets and will be exhibiting its sterile and...

LANXESS: Price adjustment for PA 6.6 compounds

LANXESS is raising its prices for Durethan A (polyamide 6.6) compounds in Europe, Middle East and Africa by EUR 0.60/kg with immediate effect. ...

Aptar Pharmaโ€™s Preservative-Free Multidose Dispenser Approved for Anti-Allergy Treatment by French Regulatory Agency ANSM

Aptar Pharmaโ€™s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved delivery device for Bausch+Lombโ€™sLevofree Multidose in France. This marks the...

Orion Contract Manufacturing enters supply agreement with Peptonic Medical

Global contract manufacturing organisation, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented...

Lonza to Host New Webinar: “Fast-Track Development of an In Vitro 3D Lung-Immune Cell Model for Enhanced Disease Modeling”

On 25 June 2018, Lonza, in collaboration with Kirkstall Ltd., a biotechnology company based in Rotherham (UK), is hosting a free 60-minute webinar on...

WuXi STA first CDMO to support the approval of an innovative drug in China through the โ€œMAHโ€ pilot

STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, announces that its partner, Ascletis has received approval from China Food and Drug...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read